AdvanSix Inc (ASIX)
Official siteBASIC MATERIALS • CHEMICALS • NYSE
Market Cap: $423.50M
Last updated: Nov 17, 2026 at 11:04 AM ET
AdvanSix Inc (ASIX) Earnings: Report Dates and Results
AdvanSix (ASIX) is expected to report earnings on Feb 18, 2027. In the quarter ended Sep 30, 2026, AdvanSix reported EPS of -$0.26, below the -$0.04 estimate. It beat the EPS estimate in 4 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
ASIX has an expected report date of Feb 18, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 1700.0% above the $0.03 reported for the quarter ended Dec 31, 2025.
ASIX Earnings Call
The latest ASIX earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 40 quarters below that had an estimate, ASIX beat 24 and missed 16. Revenue for the quarter ended Sep 30, 2026 was $430.81M, up 15.0% from $374.47M a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.26 | -$0.04 | -$0.05 - -$0.04 | -550.00% | Miss | -425.0% | 2 | 0 up, 0 down | Nov 4, 2026 | $430.81M |
| Jun 30, 2026 | $0.14 | $0.56 | $0.55 - $0.56 | -75.00% | Miss | -87.8% | 2 | 1 up, 0 down | Aug 7, 2026 | $421.28M |
| Mar 31, 2026 | -$0.56 | -$0.47 | -$0.50 - -$0.45 | -19.15% | Miss | -160.2% | 2 | 0 up, 1 down | May 8, 2026 | $404.18M |
| Dec 31, 2025 | $0.03 | -$0.06 | N/A | +150.00% | Beat | -66.7% | 1 | 0 up, 1 down | Feb 20, 2026 | $359.95M |
| Sep 30, 2025 | $0.08 | $0.40 | $0.40 - $0.40 | -80.00% | Miss | -90.9% | 1 | 0 up, 2 down | Nov 7, 2025 | $374.47M |
| Jun 30, 2025 | $1.15 | $1.11 | N/A | +3.60% | Beat | -25.8% | 1 | 0 up, 2 down | Aug 1, 2025 | $410.02M |
| Mar 31, 2025 | $0.93 | $0.83 | $0.81 - $0.84 | +12.05% | Beat | N/A | 2 | 0 up, 1 down | May 2, 2025 | $377.79M |
| Dec 31, 2024 | $0.09 | -$0.37 | -$0.40 - -$0.33 | +124.66% | Beat | N/A | 2 | 1 up, 0 down | Feb 21, 2025 | $329.06M |
| Sep 30, 2024 | $0.88 | $0.66 | $0.50 - $0.81 | +33.33% | Beat | N/A | 2 | 0 up, 0 down | Nov 1, 2024 | $398.19M |
| Jun 30, 2024 | $1.55 | $1.20 | $1.10 - $1.29 | +29.17% | Beat | +24.0% | 2 | 0 up, 0 down | Aug 2, 2024 | $453.48M |
| Mar 31, 2024 | -$0.56 | -$0.54 | -$0.67 - -$0.47 | -3.70% | Miss | -143.1% | 3 | 0 up, 0 down | May 3, 2024 | $336.83M |
| Dec 31, 2023 | -$0.10 | -$0.12 | N/A | +16.67% | Beat | -107.9% | 2 | 0 up, 0 down | Feb 16, 2024 | $382.21M |
| Sep 30, 2023 | -$0.36 | $0.10 | N/A | -460.00% | Miss | -183.7% | 3 | 0 up, 1 down | Nov 3, 2023 | $322.91M |
| Jun 30, 2023 | $1.25 | $1.11 | $0.98 - $1.15 | +12.61% | Beat | -45.7% | 3 | 0 up, 0 down | Aug 4, 2023 | $427.94M |
| Mar 31, 2023 | $1.30 | $1.02 | $0.77 - $1.23 | +27.45% | Beat | -42.5% | 3 | 0 up, 0 down | May 5, 2023 | $400.54M |
| Dec 31, 2022 | $1.27 | $1.56 | $1.42 - $1.60 | -18.59% | Miss | +58.7% | 3 | 0 up, 0 down | Feb 17, 2023 | $404.06M |
| Sep 30, 2022 | $0.43 | $0.33 | N/A | +30.30% | Beat | -71.5% | 3 | 0 up, 0 down | Nov 4, 2022 | $478.77M |
| Jun 30, 2022 | $2.30 | $2.39 | $2.23 - $2.47 | -3.77% | Miss | +50.3% | 3 | 0 up, 0 down | Aug 5, 2022 | $583.74M |
| Mar 31, 2022 | $2.26 | $1.76 | $1.53 - $1.90 | +28.41% | Beat | +130.6% | 3 | 0 up, 0 down | May 6, 2022 | $479.07M |
| Dec 31, 2021 | $0.80 | $0.81 | $0.64 - $0.91 | -1.23% | Miss | -14.9% | 3 | 0 up, 0 down | Feb 18, 2022 | $424.06M |
| Sep 30, 2021 | $1.51 | $1.27 | $1.25 - $1.30 | +18.90% | Beat | N/A | 2 | N/A | Oct 29, 2021 | $446.50M |
| Jun 30, 2021 | $1.53 | $1.08 | $0.85 - $1.31 | +41.67% | Beat | +273.2% | 2 | N/A | Jul 30, 2021 | $437.68M |
| Mar 31, 2021 | $0.98 | $0.72 | $0.66 - $0.77 | +36.11% | Beat | +216.1% | 2 | N/A | Apr 30, 2021 | $376.38M |
| Dec 31, 2020 | $0.94 | $0.49 | $0.41 - $0.56 | +91.84% | Beat | N/A | 3 | N/A | Feb 19, 2021 | $340.27M |
| Sep 30, 2020 | -$0.02 | $0.04 | -$0.10 - $0.04 | -150.00% | Miss | -107.1% | 3 | N/A | Oct 30, 2020 | $281.91M |
| Jun 30, 2020 | $0.41 | $0.37 | $0.25 - $0.39 | +10.81% | Beat | -51.8% | 3 | N/A | Jul 31, 2020 | $233.02M |
| Mar 31, 2020 | $0.31 | $0.16 | $0.15 - $0.18 | +93.75% | Beat | -54.4% | 3 | N/A | May 1, 2020 | $302.71M |
| Dec 31, 2019 | -$0.11 | -$0.08 | -$0.20 - $0.00 | -37.50% | Miss | -116.2% | 3 | N/A | Feb 21, 2020 | $326.65M |
| Sep 30, 2019 | $0.28 | $0.45 | $0.34 - $0.56 | -37.78% | Miss | +55.6% | 4 | N/A | Nov 1, 2019 | $310.63M |
| Jun 30, 2019 | $0.85 | $0.39 | $0.24 - $0.54 | +117.95% | Beat | -6.6% | 3 | N/A | Aug 1, 2019 | $345.21M |
| Mar 31, 2019 | $0.68 | $0.39 | $0.37 - $0.40 | +74.36% | Beat | +83.8% | 2 | N/A | May 3, 2019 | $314.89M |
| Dec 31, 2018 | $0.68 | $0.75 | $0.68 - $0.86 | -9.33% | Miss | +13.3% | 3 | N/A | Feb 22, 2019 | $386.63M |
| Sep 30, 2018 | $0.18 | $0.27 | $0.27 - $0.33 | -33.33% | Miss | -73.5% | 2 | N/A | Nov 2, 2018 | $368.65M |
| Jun 30, 2018 | $0.91 | $0.90 | $0.84 - $0.90 | +1.11% | Beat | +9.6% | 2 | N/A | Aug 3, 2018 | $400.46M |
| Mar 31, 2018 | $0.37 | $0.22 | $0.22 - $0.30 | +68.18% | Beat | -58.0% | 2 | N/A | May 4, 2018 | $359.24M |
| Dec 31, 2017 | $0.60 | $0.44 | $0.38 - $0.50 | +36.36% | Beat | N/A | 2 | N/A | Feb 23, 2018 | $370.19M |
| Sep 30, 2017 | $0.68 | $0.77 | $0.55 - $0.77 | -11.69% | Miss | +25.9% | 2 | N/A | Nov 7, 2017 | $366.66M |
| Jun 30, 2017 | $0.83 | $0.66 | $0.54 - $0.66 | +25.76% | Beat | N/A | 2 | N/A | Aug 10, 2017 | $361.44M |
| Mar 31, 2017 | $0.88 | $0.43 | N/A | +104.65% | Beat | N/A | N/A | N/A | May 11, 2017 | $376.70M |
| Dec 31, 2016 | -$0.81 | $0.43 | N/A | -288.37% | Miss | N/A | N/A | N/A | Mar 3, 2017 | $259.80M |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was $2.19, up 11.7% from the year before. It was -$0.27 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | $2.19 | +11.7% |
| Dec 31, 2024 | $1.96 | -6.2% |
| Dec 31, 2023 | $2.09 | -66.6% |
| Dec 31, 2022 | $6.26 | +29.9% |
| Dec 31, 2021 | $4.82 | +193.9% |
| Dec 31, 2020 | $1.64 | -3.5% |
| Dec 31, 2019 | $1.70 | -20.6% |
| Dec 31, 2018 | $2.14 | -28.4% |
| Dec 31, 2017 | $2.99 | N/A |
| Dec 31, 2016 | -$0.27 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 5,000 words across 6 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 5,017 | 6 | |
| 2026Q2 | Jun 30, 2026 | 4,462 | 6 | |
| 2026Q1 | Mar 31, 2026 | 3,758 | 6 | |
| 2025Q4 | Dec 31, 2025 | 5,665 | 6 | |
| 2025Q3 | Sep 30, 2025 | 4,214 | 5 | |
| 2025Q2 | Jun 30, 2025 | 3,564 | 5 | |
| 2025Q1 | Mar 31, 2025 | 5,294 | 6 | |
| 2024Q4 | Dec 31, 2024 | 5,546 | 6 |
2026Q3 Earnings Call
Opening remarks
Adam Kressel Vice President, Investor Relations and Treasurer Thank you, Danielle. Good morning, and welcome to AdvanSix's third quarter 2026 earnings conference call. With me here today are President and CEO, Erin Kane, and Senior Vice President and CFO, Patrick Day. This call and webcast, including any non-GAAP reconciliations, are available on our website at investors.advansix.com. Note that elements of this presentation contain forward-looking statements that are based on our best view of the world and of our business as we see it today. Those elements can change, and the actual results could differ materially from those projected, and we ask that you consider them in that light. We refer you to the forward-looking statements included in our press release and earnings presentation. In addition, we identify the principal risks and uncertainties that affect our performance in our SEC filings, including our annual report on Form 10-K, as further updated in subsequent filings with the SEC. This morning, we will review our financial results for the third quarter of 2026 and share our outlook for our key product lines and end markets. Finally, we will leave time for your questions at the end. With that, I will turn the call over to AdvanSix's President and CEO, Erin Kane.
Erin Kane President and CEO Thanks, Adam, and good morning, everyone. We appreciate you joining us here today for our quarterly call. As you saw in our press release, we generated 15% sales growth year-over-year as our teams continued to leverage both formula- and market-based pricing mechanisms to offset inflationary raw material costs. We also generated improved cash flow, benefiting from disciplined working capital performance and continued risk-based prioritization of base capital spending. While our core caprolactam operating rate continues to exceed global industry averages by nearly 10%, reduced production output at our Hopewell and backward-integrated Frankford manufacturing sites drove unfavorable fixed cost absorption. Patrick will dive into the financials in a moment, but I would like to start the discussion once again by framing our key strategic priorities. Our focus remains centered on the controllable levers that support through-cycle value creation: commercial execution, operational excellence, and disciplined capital deployment. Once again, our pricing actions in aggregate nearly offset the substantial year-over-year increase in raw materials. We are maintaining margin expansion across Nylon Solutions and Chemical Intermediates. In Plant Nutrients, while we continue to navigate elevated sulfur costs, we do expect strong domestic granular ammonium sulfate volume performance for the full 2026–2027 fertilizer year. Turning to operational excellence, we are focused on supporting safe, stable, and sustainable operations while improving earnings and cash conversion through the cycle. Our approach includes risk-based capital prioritization, disciplined turnaround scoping, and the use of continuous improvement as a productivity engine across the enterprise.
Frequently Asked Questions About ASIX
When is AdvanSix's next earnings date?
AdvanSix's next earnings report is expected for Feb 18, 2027.
Did ASIX beat earnings estimates last quarter?
No. AdvanSix reported EPS of -$0.26 for the quarter ended Sep 30, 2026, below the -$0.04 estimate by 550.00%.
What EPS do analysts expect from ASIX next quarter?
The consensus EPS estimate for AdvanSix for the quarter ending Dec 31, 2026 is $0.54 from 4 analysts, with estimates from $0.49 to $0.58.
How often does ASIX beat earnings estimates?
AdvanSix beat the EPS estimate in 4 of the last 8 quarters, with an average surprise of -54.23%.
ASIX pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors